Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan's opposition seeks to abolish Control Yuan
06/13/2025 09:53 PM - Society
Taiwan to see nine extended holidays in 2026
06/13/2025 09:09 PM - Cross-Strait
200 march in Taipei to mark 2019 Hong Kong protest, warn against China
06/13/2025 08:30 PM - Business
'Taiwan Pass' prices to soar on train fare hikes
06/13/2025 07:50 PM - Society
Student killed by falling tree at Taichung's Feng Chia University
06/13/2025 07:20 PM